Skip to main content
. 2021 Oct 19;129(3):258–266. doi: 10.1016/j.ophtha.2021.10.009

Table 1.

Summary of the Demographic, Clinical, and Psychosocial Data for the Participants Included in This Study

Variable Data
Demographic data
 Age, (yrs) 71 ± 8
 Race
 White 41 (52)
 Black 37 (47)
 Other 1 (1)
 Gender
 Women 43 (54)
 Men 36 (46)
 Education
 High school or less 7 (9)
 Higher than high school 72 (91)
 Marital status
 Married 52 (66)
 Not married 27 (34)
 Employment
 Employed full-time 4 (5)
 Not employed full-time 75 (95)
 Household income
 ≤$60 000 30 (38)
 >$60 000 21 (27)
 Declined to answer or unknown 28 (35)
Clinical data
 Comorbidities
 ≤2 46 (58)
 ≥3 33 (42)
 No. of prescribed glaucoma medications, median (IQR) 1 (1)
 No. of prescribed eye drops per day, median (IQR) 2 (2)
 Regimen complexity, median (IQR) 2 (5)
Psychosocial data
 Resilience, median (IQR) 88 (14)
 Coping, median (IQR) 59.5 (87.25)
 Coping (response sets excluded; n = 58) 71.8 (64.3–79.3)
 Glaucoma illness perception 28.5 (25.9–31.2)
 Glaucoma medication self-efficacy (n = 75), median (IQR) 30 (3)

IQR = interquartile range.

Data are presented as no. (%), mean ± standard deviation, or mean (95% confidence interval), unless otherwise indicated.